Clinical Trial Update: CC-11050 Trial in Nepalese Patients With Erythema Nodosum Leprosum [Phase 2]

View source ↗

Summary

Clinical trial update for CC-11050 in Nepalese patients with Erythema Nodosum Leprosum (ENL) in Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erythema Nodosum Leprosum
• Leprosy

Drugs mentioned

• CC-11050

Snippet

Sponsor: The Leprosy Mission Nepal | Conditions: Erythema Nodosum Leprosum, Leprosy | Phase 2 | Status: UNKNOWN